OXALIPLATIN

OXALIPLATIN was reported 75953 times

OXALIPLATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMAL VARICES 60 0.7317
1 DYSAESTHESIA PHARYNX 117 0.6686
2 PORTO-SINUSOIDAL VASCULAR DISORDER 38 0.6129
3 TYPE II HYPERSENSITIVITY 56 0.4706
4 NON-CIRRHOTIC PORTAL HYPERTENSION 159 0.4229
5 DUCTAL ADENOCARCINOMA OF PANCREAS 110 0.3971
6 ALPHA TUMOUR NECROSIS FACTOR INCREASED 33 0.3548
7 TUMOUR PERFORATION 101 0.3176
8 COLORECTAL CANCER METASTATIC 549 0.2315
9 GASTROINTESTINAL ANASTOMOTIC LEAK 82 0.2103
10 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 44 0.2066
11 NODULAR REGENERATIVE HYPERPLASIA 115 0.1791
12 ANASTOMOTIC LEAK 123 0.1772
13 HEPATECTOMY 55 0.1757
14 RECTAL CANCER METASTATIC 61 0.1753
15 MUCOSAL TOXICITY 47 0.1734
16 EVANS SYNDROME 77 0.1562
17 FOCAL NODULAR HYPERPLASIA 81 0.1558
18 ARTERIOSPASM CORONARY 598 0.1489
19 LARYNGOSPASM 397 0.1475
20 SKIN TOXICITY 707 0.1250
21 XERODERMA 32 0.1199
22 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 259 0.1174
23 RECTAL PERFORATION 63 0.1169
24 ANASTOMOTIC COMPLICATION 40 0.1163
25 VENOOCCLUSIVE LIVER DISEASE 560 0.1133
26 PORTAL VENOUS GAS 41 0.1129
27 HYPERAMMONAEMIC ENCEPHALOPATHY 185 0.1063
28 PORTAL HYPERTENSION 322 0.1043
29 PERIPHERAL SENSORY NEUROPATHY 599 0.1024
30 DERMATITIS ACNEIFORM 615 0.1010
31 METASTASES TO OVARY 32 0.1003
32 METASTASES TO PERITONEUM 239 0.0945
33 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 89 0.0940
34 GASTROINTESTINAL TOXICITY 447 0.0930
35 COLON CANCER METASTATIC 147 0.0911
36 RECTAL ADENOCARCINOMA 55 0.0909
37 INTRAVASCULAR HAEMOLYSIS 50 0.0893
38 ADENOCARCINOMA OF COLON 166 0.0885
39 CHOLINERGIC SYNDROME 56 0.0878
40 PSEUDOCIRRHOSIS 29 0.0873
41 NEUROTOXICITY 1517 0.0865
42 PARONYCHIA 375 0.0852
43 INFUSION RELATED HYPERSENSITIVITY REACTION 51 0.0849
44 STEATOHEPATITIS 45 0.0840
45 PORTAL HYPERTENSIVE GASTROPATHY 46 0.0816
46 STRIDOR 239 0.0812
47 CARCINOEMBRYONIC ANTIGEN INCREASED 155 0.0799
48 INTERLEUKIN LEVEL INCREASED 44 0.0797
49 TOXIC LEUKOENCEPHALOPATHY 57 0.0785
50 TYPE I HYPERSENSITIVITY 274 0.0778
51 CARBOHYDRATE ANTIGEN 19-9 INCREASED 40 0.0756
52 MYOCARDIAL INJURY 84 0.0747
53 GASTRIC VARICES 35 0.0743
54 TUMOUR NECROSIS 77 0.0728
55 GASTROINTESTINAL PERFORATION 299 0.0718
56 NEUTROPENIC COLITIS 147 0.0710
57 POLYNEUROPATHY 842 0.0703
58 ENTERITIS 439 0.0685
59 METASTASES TO SPLEEN 28 0.0678
60 ACUTE PROMYELOCYTIC LEUKAEMIA 66 0.0642
61 HEPATIC ATROPHY 28 0.0625
62 FULMINANT TYPE 1 DIABETES MELLITUS 63 0.0611
63 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1424 0.0610
64 ENTEROCOLITIS 351 0.0607
65 HAEMATOTOXICITY 575 0.0604
66 NECROTISING OESOPHAGITIS 30 0.0601
67 RETROPERITONEAL LYMPHADENOPATHY 31 0.0588
68 ABDOMINAL SEPSIS 51 0.0579
69 PERITONEAL DISORDER 37 0.0571
70 PROTEIN-LOSING GASTROENTEROPATHY 28 0.0563
71 BILIARY TRACT INFECTION 35 0.0563
72 GRANULOCYTE COUNT DECREASED 103 0.0555
73 VARICES OESOPHAGEAL 167 0.0552
74 ADMINISTRATION SITE EXTRAVASATION 55 0.0551
75 PERIPHERAL MOTOR NEUROPATHY 77 0.0549
76 PERFORATION 44 0.0546
77 ILEAL PERFORATION 36 0.0543
78 HEART FAILURE WITH REDUCED EJECTION FRACTION 29 0.0542
79 ADENOCARCINOMA GASTRIC 50 0.0538
80 LARYNGEAL DISCOMFORT 34 0.0534
81 STOMA SITE HAEMORRHAGE 82 0.0532
82 MYELOSUPPRESSION 1883 0.0522
83 MALIGNANT ASCITES 40 0.0522
84 DEVICE RELATED THROMBOSIS 51 0.0517
85 ENTEROVESICAL FISTULA 39 0.0514
86 VASCULAR PAIN 49 0.0514
87 MUCOSAL INFLAMMATION 1345 0.0513
88 AORTITIS 35 0.0510
89 ENTEROCUTANEOUS FISTULA 45 0.0510
90 METASTASES TO LIVER 891 0.0506
91 BONE MARROW TOXICITY 60 0.0506
92 RECALL PHENOMENON 42 0.0502
93 THERAPY PARTIAL RESPONDER 755 0.0484
94 FOLLICULAR LYMPHOMA 42 0.0477
95 DYSAESTHESIA 146 0.0476
96 NEUROPATHY PERIPHERAL 4511 0.0474
97 PNEUMATOSIS INTESTINALIS 134 0.0469
98 HYPERAMMONAEMIA 233 0.0465
99 PRINZMETAL ANGINA 45 0.0452
100 CARDIOTOXICITY 399 0.0447
101 HYPOALBUMINAEMIA 335 0.0430
102 NEUTROPENIC INFECTION 41 0.0428
103 BAND SENSATION 54 0.0426
104 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 33 0.0422
105 AMAUROSIS FUGAX 45 0.0418
106 PELVIC ABSCESS 48 0.0418
107 PELVIC FLUID COLLECTION 29 0.0411
108 PANCREATIC CARCINOMA METASTATIC 117 0.0411
109 OCULAR TOXICITY 45 0.0408
110 DIFFUSE ALVEOLAR DAMAGE 46 0.0400
111 PALMAR ERYTHEMA 46 0.0399
112 METASTASES TO LUNG 457 0.0395
113 ADENOCARCINOMA 88 0.0392
114 TUMOUR LYSIS SYNDROME 345 0.0392
115 IMMUNE THROMBOCYTOPENIA 179 0.0391
116 LIVER ABSCESS 124 0.0382
117 HYPOMAGNESAEMIA 531 0.0381
118 OESOPHAGEAL VARICES HAEMORRHAGE 82 0.0377
119 SUBILEUS 78 0.0374
120 DISEASE PROGRESSION 4383 0.0370
121 RECTAL TENESMUS 46 0.0369
122 GASTROINTESTINAL STOMA COMPLICATION 58 0.0369
123 VASOSPASM 33 0.0359
124 CYTOKINE RELEASE SYNDROME 720 0.0359
125 AORTIC THROMBOSIS 41 0.0355
126 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 116 0.0350
127 GASTRIC PERFORATION 95 0.0348
128 NEUTROPENIC SEPSIS 249 0.0348
129 METASTASES TO MENINGES 78 0.0343
130 PROTEIN URINE 31 0.0343
131 PERIPHERAL SENSORIMOTOR NEUROPATHY 43 0.0342
132 PERIPHERAL NERVE INJURY 30 0.0342
133 BONE MARROW FAILURE 689 0.0339
134 RADIATION SKIN INJURY 39 0.0336
135 SMALL INTESTINAL PERFORATION 63 0.0336
136 LEUKOENCEPHALOPATHY 124 0.0333
137 PORTAL VEIN THROMBOSIS 107 0.0331
138 DIFFUSE LARGE B-CELL LYMPHOMA 252 0.0327
139 DILATED CARDIOMYOPATHY 33 0.0326
140 THROMBOCYTOPENIA 3640 0.0325
141 LARGE INTESTINE PERFORATION 226 0.0325
142 NEUTROPENIA 4328 0.0318
143 IMMUNE-MEDIATED LUNG DISEASE 58 0.0318
144 DUODENAL PERFORATION 31 0.0316
145 CHOLANGITIS 193 0.0311
146 GENE MUTATION 61 0.0308
147 EMBOLISM ARTERIAL 37 0.0308
148 IMMUNE-MEDIATED HEPATITIS 62 0.0303
149 STRESS CARDIOMYOPATHY 176 0.0302
150 AZOTAEMIA 120 0.0300
151 PROCTITIS 83 0.0296
152 XEROSIS 36 0.0291
153 INTESTINAL ISCHAEMIA 159 0.0288
154 OBSTRUCTION GASTRIC 37 0.0287
155 SYSTEMIC INFECTION 47 0.0283
156 ACUTE ABDOMEN 41 0.0279
157 FEBRILE NEUTROPENIA 1853 0.0279
158 IMMUNE-MEDIATED MYOCARDITIS 45 0.0278
159 LYMPHANGIOSIS CARCINOMATOSA 29 0.0278
160 INTESTINAL PERFORATION 312 0.0278
161 HYPERBILIRUBINAEMIA 287 0.0277
162 RECTAL CANCER 85 0.0276
163 CATHETER RELATED INFECTION 28 0.0276
164 EXTRAVASATION 113 0.0275
165 LARYNGEAL OEDEMA 169 0.0274
166 METASTASES TO LYMPH NODES 185 0.0274
167 ADENOCARCINOMA PANCREAS 35 0.0272
168 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 161 0.0272
169 ACUTE CORONARY SYNDROME 225 0.0271
170 LEUKOPENIA 1358 0.0271
171 ASCITES 798 0.0271
172 IMMUNE-MEDIATED ENTEROCOLITIS 99 0.0269
173 KLEBSIELLA SEPSIS 30 0.0266
174 TUMOUR HAEMORRHAGE 76 0.0266
175 ILEUS 330 0.0265
176 PROTEINURIA 492 0.0259
177 BRONCHOSPASM 369 0.0258
178 IMMUNE THROMBOCYTOPENIC PURPURA 73 0.0258
179 VOCAL CORD PARALYSIS 46 0.0256
180 THROMBOCYTOPENIC PURPURA 35 0.0256
181 PHARYNGEAL PARAESTHESIA 40 0.0252
182 FIXED ERUPTION 43 0.0250
183 URETERIC OBSTRUCTION 34 0.0249
184 SPLENOMEGALY 292 0.0249
185 ANAPHYLACTOID REACTION 102 0.0248
186 HYPOPROTEINAEMIA 47 0.0247
187 CACHEXIA 127 0.0247
188 APLASIA 48 0.0245
189 NEUTROPHIL COUNT DECREASED 999 0.0245
190 ABDOMINAL INFECTION 62 0.0242
191 CHOLANGIOCARCINOMA 36 0.0242
192 LARGE INTESTINAL OBSTRUCTION 54 0.0242
193 VENA CAVA THROMBOSIS 40 0.0241
194 LYMPHADENOPATHY MEDIASTINAL 46 0.0240
195 FEMALE GENITAL TRACT FISTULA 41 0.0240
196 BLOOD LACTATE DEHYDROGENASE INCREASED 378 0.0238
197 EMBOLISM 197 0.0237
198 ASPARTATE AMINOTRANSFERASE ABNORMAL 36 0.0236
199 RASH PUSTULAR 172 0.0236
200 JUGULAR VEIN THROMBOSIS 42 0.0236
201 HYPERTHERMIA 179 0.0234
202 VENTRICULAR DYSFUNCTION 60 0.0231
203 IMMUNE-MEDIATED HEPATIC DISORDER 45 0.0231
204 ONYCHOLYSIS 36 0.0230
205 PERFORMANCE STATUS DECREASED 107 0.0229
206 HEPATIC LESION 99 0.0229
207 ABDOMINAL ABSCESS 101 0.0228
208 WOUND DEHISCENCE 77 0.0228
209 ARTERIAL THROMBOSIS 44 0.0227
210 HYPOVOLAEMIC SHOCK 109 0.0227
211 EMBOLISM VENOUS 68 0.0224
212 PERIPHERAL ISCHAEMIA 91 0.0223
213 HYPERPYREXIA 94 0.0222
214 BILE DUCT OBSTRUCTION 42 0.0221
215 ESCHERICHIA BACTERAEMIA 52 0.0221
216 OESOPHAGEAL HAEMORRHAGE 29 0.0219
217 PULMONARY TOXICITY 154 0.0218
218 TONGUE OEDEMA 83 0.0217
219 DISSEMINATED INTRAVASCULAR COAGULATION 305 0.0216
220 GASTROINTESTINAL NECROSIS 63 0.0216
221 NEUTROPHIL COUNT ABNORMAL 61 0.0216
222 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 205 0.0215
223 NEOPLASM PROGRESSION 745 0.0214
224 INTERSTITIAL LUNG DISEASE 1032 0.0213
225 HYPOKALAEMIA 981 0.0212
226 HICCUPS 172 0.0209
227 NEOPLASM RECURRENCE 71 0.0209
228 GASTROINTESTINAL OEDEMA 37 0.0209
229 ALANINE AMINOTRANSFERASE ABNORMAL 44 0.0208
230 CYTOPENIA 254 0.0207
231 HAEMOLYTIC URAEMIC SYNDROME 48 0.0207
232 HAEMOLYTIC ANAEMIA 184 0.0205
233 NECROTISING FASCIITIS 72 0.0204
234 ORGANISING PNEUMONIA 101 0.0204
235 HYPERAEMIA 40 0.0203
236 PNEUMOPERITONEUM 37 0.0200
237 VENOOCCLUSIVE DISEASE 50 0.0200
238 SECONDARY ADRENOCORTICAL INSUFFICIENCY 30 0.0199
239 HYDRONEPHROSIS 148 0.0197
240 BLOOD ALBUMIN DECREASED 156 0.0196
241 BLOOD PRESSURE IMMEASURABLE 30 0.0196
242 PELVIC VENOUS THROMBOSIS 28 0.0195
243 JAUNDICE CHOLESTATIC 68 0.0192
244 GASTROINTESTINAL OBSTRUCTION 46 0.0191
245 BILIARY DILATATION 28 0.0190
246 METASTASIS 136 0.0190
247 LUNG OPACITY 50 0.0190
248 GASTROINTESTINAL ULCER 42 0.0189
249 AUTOIMMUNE HAEMOLYTIC ANAEMIA 64 0.0187
250 THROMBOTIC MICROANGIOPATHY 180 0.0185
251 HEPATIC FIBROSIS 63 0.0183
252 HEPATIC CYTOLYSIS 234 0.0183
253 HYPERTENSIVE CRISIS 204 0.0183
254 HYPERTRANSAMINASAEMIA 127 0.0182
255 VENOUS THROMBOSIS 71 0.0181
256 VENTRICULAR HYPOKINESIA 58 0.0180
257 ILEUS PARALYTIC 80 0.0179
258 HYPERTRICHOSIS 33 0.0178
259 STOMATITIS 1076 0.0177
260 LEFT VENTRICULAR FAILURE 61 0.0177
261 METASTATIC NEOPLASM 76 0.0176
262 THROMBOTIC THROMBOCYTOPENIC PURPURA 62 0.0176
263 LEFT VENTRICULAR DYSFUNCTION 117 0.0174
264 SEPTIC SHOCK 759 0.0174
265 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 31 0.0174
266 TEMPERATURE INTOLERANCE 179 0.0173
267 MALIGNANT NEOPLASM PROGRESSION 1770 0.0173
268 RESPIRATORY ALKALOSIS 28 0.0172
269 DUODENAL ULCER 120 0.0170
270 SMALL INTESTINAL OBSTRUCTION 207 0.0168
271 OESOPHAGITIS 181 0.0166
272 ELECTROLYTE IMBALANCE 191 0.0164
273 HYPERTRIGLYCERIDAEMIA 96 0.0164
274 DYSENTERY 30 0.0161
275 PNEUMOMEDIASTINUM 29 0.0160
276 MONOPARESIS 29 0.0160
277 CUTANEOUS LUPUS ERYTHEMATOSUS 31 0.0159
278 TRISMUS 82 0.0159
279 ORAL INTAKE REDUCED 38 0.0157
280 GUILLAIN-BARRE SYNDROME 76 0.0157
281 ACUTE RESPIRATORY DISTRESS SYNDROME 277 0.0156
282 SKIN REACTION 219 0.0155
283 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 34 0.0155
284 VENTRICULAR FIBRILLATION 171 0.0154
285 HAEMOGLOBIN ABNORMAL 98 0.0152
286 NEPHROTIC SYNDROME 104 0.0152
287 HISTIOCYTOSIS HAEMATOPHAGIC 45 0.0151
288 SUSPECTED OFF LABEL USE 68 0.0150
289 HEPATIC FUNCTION ABNORMAL 561 0.0150
290 HEPATIC ENCEPHALOPATHY 140 0.0150
291 TONGUE DISORDER 108 0.0149
292 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 39 0.0147
293 COLON CANCER 218 0.0146
294 PROCTALGIA 94 0.0146
295 HYPOPHOSPHATAEMIA 108 0.0146
296 VENOUS THROMBOSIS LIMB 30 0.0145
297 GASTROINTESTINAL INJURY 39 0.0145
298 THROAT TIGHTNESS 392 0.0145
299 PNEUMONITIS 389 0.0143
300 SUDDEN DEATH 150 0.0142
301 CHOLESTASIS 272 0.0142
302 HEPATIC FAILURE 426 0.0141
303 OESOPHAGEAL STENOSIS 40 0.0140
304 CAPILLARY LEAK SYNDROME 29 0.0140
305 DYSARTHRIA 528 0.0140
306 DUODENITIS 43 0.0140
307 ANAPHYLACTIC SHOCK 360 0.0139
308 SECOND PRIMARY MALIGNANCY 116 0.0139
309 FEBRILE BONE MARROW APLASIA 59 0.0139
310 COLITIS 525 0.0138
311 PARAESTHESIA ORAL 199 0.0138
312 TACHYARRHYTHMIA 34 0.0136
313 HEPATOCELLULAR INJURY 193 0.0136
314 INTESTINAL OBSTRUCTION 513 0.0136
315 HEPATOTOXICITY 303 0.0136
316 TACHYPNOEA 184 0.0135
317 CARDIOGENIC SHOCK 194 0.0135
318 CHOLESTATIC LIVER INJURY 30 0.0135
319 HAEMOLYSIS 104 0.0135
320 PANCYTOPENIA 749 0.0134
321 INFUSION RELATED REACTION 888 0.0134
322 THROMBOCYTOSIS 49 0.0134
323 FIBROSIS 41 0.0133
324 ANAEMIA 2515 0.0132
325 ABDOMINAL MASS 35 0.0131
326 HYPERPHOSPHATAEMIA 28 0.0130
327 AMYLASE INCREASED 48 0.0130
328 PSEUDOMEMBRANOUS COLITIS 29 0.0130
329 FAILURE TO THRIVE 67 0.0129
330 KLEBSIELLA INFECTION 65 0.0128
331 PAPILLOEDEMA 58 0.0128
332 HYPOCALCAEMIA 243 0.0128
333 TYPE IV HYPERSENSITIVITY REACTION 35 0.0128
334 CLOSTRIDIAL INFECTION 43 0.0127
335 TOXIC ENCEPHALOPATHY 64 0.0126
336 DRUG-INDUCED LIVER INJURY 392 0.0125
337 PERITONITIS 258 0.0124
338 BLOOD BILIRUBIN INCREASED 336 0.0124
339 MUSCLE CONTRACTIONS INVOLUNTARY 43 0.0122
340 MYOCARDIAL ISCHAEMIA 139 0.0122
341 OXYGEN SATURATION DECREASED 686 0.0122
342 ACUTE MYELOID LEUKAEMIA 190 0.0122
343 CARDIAC FAILURE ACUTE 80 0.0120
344 CONGESTIVE CARDIOMYOPATHY 50 0.0120
345 MALNUTRITION 134 0.0120
346 LIVER INJURY 294 0.0120
347 PLATELET COUNT DECREASED 1275 0.0120
348 BACTERAEMIA 141 0.0119
349 CIRCULATORY COLLAPSE 200 0.0117
350 PULMONARY FIBROSIS 222 0.0116
351 SHOCK HAEMORRHAGIC 94 0.0115
352 SEPSIS 1282 0.0115
353 TUMOUR MARKER INCREASED 55 0.0115
354 ACUTE PULMONARY OEDEMA 64 0.0114
355 METASTASES TO CENTRAL NERVOUS SYSTEM 147 0.0114
356 BLOOD CULTURE POSITIVE 34 0.0113
357 LIP OEDEMA 48 0.0113
358 GENERAL PHYSICAL HEALTH DETERIORATION 1308 0.0113
359 CEREBRAL ISCHAEMIA 58 0.0113
360 MULTIPLE ORGAN DYSFUNCTION SYNDROME 317 0.0112
361 ANAPHYLACTIC REACTION 616 0.0111
362 DEHYDRATION 1487 0.0111
363 PULMONARY EMBOLISM 1052 0.0111
364 CYANOSIS 174 0.0111
365 DIARRHOEA 7075 0.0109
366 OLIGURIA 68 0.0109
367 HYPOVOLAEMIA 64 0.0109
368 ODYNOPHAGIA 65 0.0109
369 RASH MACULO-PAPULAR 241 0.0108
370 BLOOD LACTIC ACID INCREASED 57 0.0108
371 BLOOD ALKALINE PHOSPHATASE INCREASED 268 0.0108
372 OESOPHAGEAL CANDIDIASIS 43 0.0108
373 ESCHERICHIA SEPSIS 31 0.0107
374 HYPERSENSITIVITY VASCULITIS 28 0.0107
375 METABOLIC ENCEPHALOPATHY 32 0.0107
376 NORMOCHROMIC NORMOCYTIC ANAEMIA 32 0.0106
377 TROPONIN INCREASED 81 0.0106
378 CHILLS 1244 0.0106
379 ENCEPHALOPATHY 260 0.0106
380 MYELODYSPLASTIC SYNDROME 152 0.0105
381 CARDIAC DYSFUNCTION 39 0.0105
382 LEUKOCYTOSIS 189 0.0104
383 NEPHROPATHY TOXIC 117 0.0104
384 HAEMATEMESIS 264 0.0104
385 HEPATITIS B REACTIVATION 33 0.0104
386 TRANSAMINASES INCREASED 231 0.0104
387 PARAESTHESIA 1632 0.0104
388 CHOKING SENSATION 57 0.0103
389 CATHETER SITE INFECTION 39 0.0103
390 PLATELET COUNT ABNORMAL 62 0.0102
391 ISCHAEMIA 47 0.0102
392 PIGMENTATION DISORDER 63 0.0102
393 ATELECTASIS 98 0.0101
394 DEVICE RELATED INFECTION 156 0.0101
395 ACUTE MYOCARDIAL INFARCTION 298 0.0101
396 HYPOAESTHESIA ORAL 152 0.0101
397 LUNG CONSOLIDATION 28 0.0100
398 MULTIPLE-DRUG RESISTANCE 31 0.0100
399 THROMBOPHLEBITIS 35 0.0100
400 HYPERURICAEMIA 41 0.0100
401 MYOCARDITIS 114 0.0099
402 CHOLECYSTITIS ACUTE 56 0.0099
403 WHITE BLOOD CELL COUNT ABNORMAL 63 0.0099
404 SHOCK 227 0.0099
405 JAUNDICE 265 0.0098
406 METABOLIC DISORDER 57 0.0098
407 PHLEBITIS 50 0.0098
408 SENSATION OF FOREIGN BODY 82 0.0097
409 RESPIRATORY DISTRESS 268 0.0097
410 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 37 0.0097
411 CARDIOMYOPATHY 143 0.0097
412 VOMITING 4522 0.0096
413 WOUND COMPLICATION 33 0.0096
414 WHITE BLOOD CELL COUNT DECREASED 1042 0.0096
415 DECREASED APPETITE 2214 0.0095
416 CYTOMEGALOVIRUS INFECTION REACTIVATION 42 0.0095
417 EPIGASTRIC DISCOMFORT 37 0.0095
418 PULSE ABSENT 45 0.0095
419 LYMPHOMA 146 0.0094
420 LUNG INFILTRATION 83 0.0094
421 ANAL FISTULA 50 0.0094
422 PLEURAL EFFUSION 570 0.0094
423 HEPATITIS CHOLESTATIC 56 0.0093
424 HEPATIC NECROSIS 35 0.0093
425 VASCULAR DEVICE INFECTION 42 0.0092
426 AGRANULOCYTOSIS 172 0.0092
427 FISTULA 104 0.0092
428 NECROSIS 51 0.0092
429 CHOLECYSTITIS 109 0.0091
430 PNEUMOTHORAX 145 0.0091
431 SINUS TACHYCARDIA 129 0.0091
432 DEEP VEIN THROMBOSIS 589 0.0091
433 CLOSTRIDIUM DIFFICILE COLITIS 96 0.0090
434 ANOREXIA 116 0.0090
435 STAPHYLOCOCCAL BACTERAEMIA 39 0.0090
436 RESPIRATORY FAILURE 653 0.0089
437 STAPHYLOCOCCAL SEPSIS 44 0.0089
438 COLITIS ISCHAEMIC 60 0.0089
439 ABDOMINAL PAIN 2067 0.0089
440 CHRONIC MYELOID LEUKAEMIA 41 0.0089
441 SUPRAVENTRICULAR TACHYCARDIA 85 0.0089
442 OROPHARYNGEAL DISCOMFORT 80 0.0088
443 HEPATIC CYST 30 0.0088
444 ASPARTATE AMINOTRANSFERASE INCREASED 469 0.0088
445 PNEUMONIA BACTERIAL 81 0.0088
446 TACHYCARDIA 781 0.0088
447 RALES 51 0.0088
448 HEPATITIS ACUTE 57 0.0088
449 GAMMA-GLUTAMYLTRANSFERASE INCREASED 194 0.0087
450 LYMPHOPENIA 123 0.0087
451 AORTIC DISSECTION 36 0.0087
452 ABDOMINAL TENDERNESS 43 0.0087
453 OESOPHAGEAL ULCER 33 0.0086
454 MYOSITIS 77 0.0086
455 ACUTE KIDNEY INJURY 1304 0.0085
456 PYREXIA 2946 0.0085
457 ACUTE RESPIRATORY FAILURE 163 0.0085
458 SARCOIDOSIS 40 0.0084
459 FUNCTIONAL GASTROINTESTINAL DISORDER 29 0.0084
460 APHTHOUS ULCER 65 0.0084
461 DIARRHOEA HAEMORRHAGIC 78 0.0083
462 DERMATITIS EXFOLIATIVE GENERALISED 29 0.0083
463 HYPOPHAGIA 213 0.0083
464 MULTI-ORGAN FAILURE 143 0.0083
465 PNEUMOCYSTIS JIROVECII PNEUMONIA 83 0.0083
466 PURPURA 73 0.0082
467 LIPASE INCREASED 63 0.0082
468 ANGIOPATHY 46 0.0082
469 PANCREATITIS ACUTE 184 0.0082
470 CONJUNCTIVAL HYPERAEMIA 29 0.0081
471 ANGINA PECTORIS 233 0.0081
472 BRONCHOPULMONARY ASPERGILLOSIS 63 0.0081
473 DRUG RESISTANCE 208 0.0081
474 CONJUNCTIVITIS 150 0.0081
475 GRANULOCYTOPENIA 46 0.0081
476 ALANINE AMINOTRANSFERASE INCREASED 493 0.0080
477 PROTEIN URINE PRESENT 40 0.0080
478 FEMORAL NECK FRACTURE 41 0.0080
479 EJECTION FRACTION DECREASED 124 0.0080
480 HEPATITIS B 48 0.0080
481 HYPONATRAEMIA 448 0.0079
482 RED CELL DISTRIBUTION WIDTH INCREASED 33 0.0079
483 NEUTROPHILIA 45 0.0079
484 BLOOD CREATINE INCREASED 35 0.0079
485 BODY TEMPERATURE INCREASED 161 0.0079
486 GASTROENTERITIS 115 0.0079
487 SKIN FISSURES 154 0.0079
488 HAEMODYNAMIC INSTABILITY 60 0.0079
489 WOUND INFECTION 85 0.0078
490 FLUSHING 789 0.0078
491 C-REACTIVE PROTEIN INCREASED 282 0.0077
492 ASPHYXIA 63 0.0077
493 BREATH SOUNDS ABNORMAL 38 0.0077
494 DISEASE RECURRENCE 366 0.0077
495 HEPATIC STEATOSIS 143 0.0077
496 BLOOD PHOSPHORUS DECREASED 28 0.0077
497 FOLLICULITIS 80 0.0076
498 STATUS EPILEPTICUS 86 0.0076
499 UROSEPSIS 70 0.0076
500 COLD SWEAT 133 0.0075
501 NEUROLOGICAL SYMPTOM 43 0.0075
502 HYPERCALCAEMIA 92 0.0074
503 ANURIA 64 0.0074
504 GASTRIC ULCER 141 0.0074
505 ESCHERICHIA INFECTION 61 0.0074
506 ALTERED STATE OF CONSCIOUSNESS 160 0.0074
507 ORAL CANDIDIASIS 97 0.0074
508 HYPOXIA 258 0.0073
509 BLEPHAROSPASM 46 0.0073
510 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 75 0.0073
511 ESCHERICHIA URINARY TRACT INFECTION 31 0.0073
512 ISCHAEMIC STROKE 130 0.0073
513 HAEMATURIA 249 0.0073
514 OBSTRUCTION 29 0.0073
515 CARDIO-RESPIRATORY ARREST 303 0.0072
516 BLOOD DISORDER 58 0.0072
517 CHEILITIS 39 0.0072
518 METASTASES TO BONE 118 0.0072
519 DYSPHONIA 420 0.0072
520 NAUSEA 5659 0.0071
521 HEMIPARESIS 121 0.0071
522 SKIN NECROSIS 37 0.0071
523 DRUG TOXICITY 97 0.0071
524 HYPOTENSION 1428 0.0071
525 HYPOTHERMIA 72 0.0071
526 SKIN HYPERPIGMENTATION 61 0.0071
527 ARTERIOSCLEROSIS CORONARY ARTERY 47 0.0071
528 ADRENAL INSUFFICIENCY 86 0.0071
529 UPPER GASTROINTESTINAL HAEMORRHAGE 119 0.0071
530 MOUTH ULCERATION 149 0.0071
531 ERYTHEMA 1453 0.0071
532 INCORRECT DRUG ADMINISTRATION RATE 30 0.0070
533 VENTRICULAR TACHYCARDIA 116 0.0070
534 ELECTROCARDIOGRAM ABNORMAL 55 0.0070
535 CORONARY ARTERY STENOSIS 35 0.0070
536 HYPERTENSION 1469 0.0069
537 ASPERGILLUS INFECTION 45 0.0068
538 CARDIAC ARREST 566 0.0068
539 FEELING HOT 420 0.0068
540 DYSPHAGIA 650 0.0068
541 HYPERNATRAEMIA 34 0.0068
542 PNEUMONIA ASPIRATION 170 0.0068
543 ACIDOSIS 52 0.0068
544 ATRIAL FLUTTER 54 0.0068
545 NAIL DISORDER 59 0.0067
546 SPEECH DISORDER 353 0.0067
547 GENERALISED ERYTHEMA 38 0.0067
548 ANAL ABSCESS 36 0.0067
549 RENAL TUBULAR NECROSIS 65 0.0066
550 COAGULOPATHY 110 0.0066
551 HYPERGLYCAEMIA 240 0.0066
552 TOXIC EPIDERMAL NECROLYSIS 100 0.0066
553 HYPERAESTHESIA 54 0.0066
554 LUNG NEOPLASM 28 0.0065
555 BLOOD CREATININE INCREASED 428 0.0065
556 HYPERHIDROSIS 843 0.0065
557 NEUTROPHIL COUNT INCREASED 67 0.0065
558 COVID-19 PNEUMONIA 77 0.0065
559 PETECHIAE 68 0.0065
560 HEPATOMEGALY 64 0.0065
561 GASTROINTESTINAL INFLAMMATION 51 0.0065
562 LYMPHOCYTE COUNT DECREASED 115 0.0065
563 TORSADE DE POINTES 51 0.0065
564 EYELID PTOSIS 66 0.0065
565 RENAL FAILURE ACUTE 275 0.0065
566 MELAENA 142 0.0064
567 ASTHENIA 2424 0.0064
568 PALLOR 174 0.0064
569 CEREBRAL INFARCTION 156 0.0064
570 PULMONARY MASS 95 0.0064
571 HYPERSENSITIVITY 1176 0.0063
572 HEPATITIS 162 0.0063
573 LYMPHADENOPATHY 223 0.0063
574 APHASIA 190 0.0063
575 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 47 0.0063
576 INFLAMMATORY MARKER INCREASED 31 0.0062
577 ATAXIA 74 0.0062
578 METABOLIC ACIDOSIS 197 0.0062
579 UNRESPONSIVE TO STIMULI 158 0.0061
580 PRESYNCOPE 148 0.0061
581 TOXIC SKIN ERUPTION 61 0.0061
582 EPISTAXIS 453 0.0060
583 MUSCLE RIGIDITY 72 0.0060
584 ENTEROCOCCAL INFECTION 29 0.0060
585 RECTAL HAEMORRHAGE 257 0.0060
586 PERIPHERAL COLDNESS 82 0.0060
587 SKIN DISORDER 199 0.0060
588 LOWER GASTROINTESTINAL HAEMORRHAGE 44 0.0059
589 ACUTE HEPATIC FAILURE 81 0.0059
590 CANDIDA INFECTION 100 0.0059
591 BLOOD MAGNESIUM DECREASED 51 0.0059
592 ERYTHEMA MULTIFORME 55 0.0059
593 DERMATITIS 123 0.0059
594 PROTHROMBIN TIME PROLONGED 35 0.0058
595 DEFAECATION URGENCY 41 0.0058
596 CHEST DISCOMFORT 599 0.0058
597 TOXICITY TO VARIOUS AGENTS 983 0.0058
598 GENERALISED OEDEMA 71 0.0057
599 HAEMORRHOIDAL HAEMORRHAGE 28 0.0057
600 HYPERKALAEMIA 201 0.0057
601 GINGIVAL BLEEDING 78 0.0057
602 BLINDNESS TRANSIENT 42 0.0057
603 FEELING COLD 158 0.0057
604 TUBULOINTERSTITIAL NEPHRITIS 106 0.0057
605 TYPE 1 DIABETES MELLITUS 34 0.0056
606 PERONEAL NERVE PALSY 32 0.0056
607 RENAL IMPAIRMENT 473 0.0056
608 GASTROINTESTINAL CARCINOMA 51 0.0056
609 DYSPNOEA 3140 0.0055
610 HAEMOGLOBIN DECREASED 569 0.0055
611 PULMONARY ALVEOLAR HAEMORRHAGE 31 0.0055
612 LIVER DISORDER 245 0.0055
613 OFF LABEL USE 4825 0.0055
614 POLYARTHRITIS 29 0.0055
615 MOTOR DYSFUNCTION 56 0.0055
616 ABSCESS 87 0.0054
617 ANAL INCONTINENCE 49 0.0054
618 GASTROINTESTINAL DISORDER 488 0.0054
619 ANAL FISSURE 29 0.0054
620 FACE OEDEMA 91 0.0054
621 ANGINA UNSTABLE 35 0.0054
622 DEPRESSED LEVEL OF CONSCIOUSNESS 213 0.0054
623 BRONCHIECTASIS 36 0.0053
624 PERICARDIAL EFFUSION 123 0.0053
625 SWOLLEN TONGUE 166 0.0053
626 RETCHING 113 0.0053
627 HYPOTHYROIDISM 169 0.0053
628 GRAFT VERSUS HOST DISEASE 38 0.0053
629 IMMUNE SYSTEM DISORDER 69 0.0052
630 ONYCHOCLASIS 36 0.0052
631 ATRIAL FIBRILLATION 509 0.0052
632 GASTROINTESTINAL HAEMORRHAGE 435 0.0052
633 ENCEPHALITIS 36 0.0052
634 IRON DEFICIENCY ANAEMIA 48 0.0052
635 BLOOD SODIUM DECREASED 98 0.0052
636 HYPOAESTHESIA 772 0.0052
637 INFECTION 744 0.0051
638 ORAL PAIN 114 0.0051
639 GASTRIC ULCER HAEMORRHAGE 28 0.0050
640 ASPIRATION 55 0.0050
641 FLANK PAIN 47 0.0050
642 RENAL FAILURE 664 0.0050
643 MENTAL STATUS CHANGES 138 0.0050
644 POSTOPERATIVE WOUND INFECTION 33 0.0049
645 SKIN LESION 134 0.0049
646 BACTERIAL INFECTION 91 0.0049
647 DIABETIC KETOACIDOSIS 117 0.0049
648 GASTRIC HAEMORRHAGE 56 0.0049
649 ABDOMINAL PAIN LOWER 123 0.0049
650 BLOOD URIC ACID INCREASED 28 0.0048
651 HAEMATOCRIT DECREASED 96 0.0048
652 BLOOD UREA INCREASED 81 0.0048
653 CARDIAC FAILURE 388 0.0048
654 ATRIOVENTRICULAR BLOCK COMPLETE 32 0.0048
655 PLEURISY 28 0.0047
656 THERAPY NON-RESPONDER 211 0.0047
657 BLOOD POTASSIUM DECREASED 141 0.0047
658 RENAL FAILURE CHRONIC 36 0.0047
659 PRODUCT USE IN UNAPPROVED INDICATION 1154 0.0047
660 TRANSIENT ISCHAEMIC ATTACK 157 0.0046
661 GENERALISED TONIC-CLONIC SEIZURE 77 0.0046
662 LOSS OF CONSCIOUSNESS 594 0.0046
663 SUBARACHNOID HAEMORRHAGE 47 0.0046
664 LUNG DISORDER 226 0.0046
665 SALIVARY HYPERSECRETION 46 0.0046
666 VASCULITIS 53 0.0045
667 BLOOD CALCIUM DECREASED 51 0.0045
668 RESPIRATORY RATE INCREASED 40 0.0045
669 NEURALGIA 109 0.0045
670 FORMICATION 31 0.0045
671 VISUAL FIELD DEFECT 32 0.0044
672 MITRAL VALVE INCOMPETENCE 50 0.0044
673 HEPATIC CIRRHOSIS 83 0.0044
674 TASTE DISORDER 89 0.0044
675 CONSTIPATION 954 0.0044
676 RETINAL HAEMORRHAGE 31 0.0043
677 EXTRASYSTOLES 30 0.0043
678 SYNCOPE 429 0.0043
679 DERMATITIS BULLOUS 31 0.0043
680 BLOOD PRESSURE DECREASED 284 0.0043
681 DRUG INTOLERANCE 411 0.0043
682 CHEST PAIN 786 0.0042
683 LIP SWELLING 141 0.0042
684 OEDEMA PERIPHERAL 516 0.0042
685 HAEMODIALYSIS 35 0.0042
686 RENAL CYST 33 0.0042
687 STAPHYLOCOCCAL INFECTION 137 0.0041
688 BRADYCARDIA 220 0.0041
689 RETINAL DETACHMENT 38 0.0041
690 FAECES SOFT 30 0.0041
691 EPILEPSY 126 0.0041
692 PARALYSIS 59 0.0041
693 GRAND MAL CONVULSION 38 0.0041
694 POST PROCEDURAL COMPLICATION 79 0.0041
695 TREATMENT FAILURE 340 0.0041
696 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 291 0.0041
697 OEDEMA 220 0.0041
698 GASTRITIS 106 0.0040
699 DYSGEUSIA 298 0.0040
700 ARRHYTHMIA 189 0.0040
701 PERICARDITIS 67 0.0040
702 OPTIC NEURITIS 36 0.0040
703 URINARY RETENTION 132 0.0040
704 DRUG ERUPTION 70 0.0039
705 HEPATOCELLULAR CARCINOMA 30 0.0039
706 HAEMOPTYSIS 110 0.0039
707 DYSPNOEA EXERTIONAL 148 0.0039
708 PYELONEPHRITIS 34 0.0039
709 NEOPLASM 45 0.0039
710 COMA 186 0.0039
711 ULCER 62 0.0039
712 WHITE BLOOD CELL COUNT INCREASED 148 0.0039
713 NO THERAPEUTIC RESPONSE 47 0.0039
714 HEMIPLEGIA 32 0.0038
715 SKIN ULCER 99 0.0038
716 RASH 1666 0.0038
717 ORAL DISORDER 28 0.0038
718 MOUTH HAEMORRHAGE 28 0.0038
719 DELIRIUM 132 0.0038
720 FATIGUE 2954 0.0038
721 HAEMORRHAGE 396 0.0038
722 POST PROCEDURAL HAEMORRHAGE 44 0.0038
723 DIPLOPIA 98 0.0038
724 LACTIC ACIDOSIS 122 0.0038
725 VENTRICULAR EXTRASYSTOLES 39 0.0038
726 FACIAL PARALYSIS 32 0.0038
727 ELECTROCARDIOGRAM QT PROLONGED 135 0.0037
728 HAEMATOCHEZIA 207 0.0037
729 KETOACIDOSIS 28 0.0037
730 PSEUDOMONAS INFECTION 32 0.0037
731 DYSURIA 137 0.0037
732 EYELID OEDEMA 43 0.0037
733 PNEUMONIA 1195 0.0037
734 IMPAIRED QUALITY OF LIFE 53 0.0037
735 HYPERTHYROIDISM 53 0.0037
736 WEIGHT DECREASED 1021 0.0037
737 STEVENS-JOHNSON SYNDROME 81 0.0036
738 DEVICE OCCLUSION 51 0.0036
739 CLOSTRIDIUM DIFFICILE INFECTION 79 0.0036
740 THROMBOSIS 290 0.0036
741 IMPAIRED GASTRIC EMPTYING 49 0.0036
742 PULMONARY HAEMORRHAGE 28 0.0036
743 MUSCLE TWITCHING 82 0.0036
744 SENSORY DISTURBANCE 57 0.0035
745 TENDERNESS 37 0.0035
746 URINE OUTPUT DECREASED 31 0.0035
747 THROAT IRRITATION 159 0.0035
748 URINARY INCONTINENCE 104 0.0035
749 PHARYNGEAL SWELLING 34 0.0035
750 MYOPATHY 30 0.0035
751 EMPHYSEMA 34 0.0034
752 GASTROINTESTINAL PAIN 37 0.0034
753 RED BLOOD CELL COUNT DECREASED 96 0.0034
754 LUNG INFECTION 52 0.0033
755 ABDOMINAL DISTENSION 348 0.0033
756 PULMONARY OEDEMA 148 0.0033
757 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
758 PERSONALITY CHANGE 30 0.0032
759 PRURITUS 1241 0.0032
760 MALAISE 1413 0.0032
761 INCONTINENCE 34 0.0032
762 PRODUCT PRESCRIBING ISSUE 70 0.0032
763 TREMOR 533 0.0032
764 INFUSION SITE PAIN 41 0.0032
765 FEEDING DISORDER 64 0.0032
766 IMPAIRED HEALING 103 0.0031
767 PANCREATITIS 165 0.0031
768 GASTRIC CANCER 79 0.0031
769 SINUS BRADYCARDIA 30 0.0031
770 ORTHOSTATIC HYPOTENSION 54 0.0031
771 WHEEZING 182 0.0031
772 MUSCULAR WEAKNESS 346 0.0030
773 SKIN INFECTION 34 0.0030
774 LIVER FUNCTION TEST ABNORMAL 88 0.0030
775 INTENTIONAL PRODUCT USE ISSUE 265 0.0030
776 BRAIN OEDEMA 38 0.0030
777 CARDIOMEGALY 37 0.0030
778 DISORIENTATION 119 0.0030
779 ILL-DEFINED DISORDER 182 0.0030
780 RESPIRATORY TRACT INFECTION 78 0.0030
781 NERVOUS SYSTEM DISORDER 93 0.0030
782 MUSCLE SPASMS 537 0.0029
783 COGNITIVE DISORDER 136 0.0029
784 COLORECTAL CANCER 137 0.0029
785 DERMATITIS ALLERGIC 36 0.0029
786 HYPERLIPIDAEMIA 34 0.0028
787 ORAL DISCOMFORT 39 0.0028
788 RASH ERYTHEMATOUS 134 0.0028
789 OSTEONECROSIS OF JAW 69 0.0028
790 DIVERTICULITIS 77 0.0028
791 PERITONITIS BACTERIAL 28 0.0028
792 FUNGAL INFECTION 92 0.0028
793 APHONIA 38 0.0027
794 DEATH 2342 0.0027
795 INFLAMMATION 140 0.0027
796 DRUG INTERACTION 430 0.0027
797 ABDOMINAL PAIN UPPER 557 0.0027
798 HEPATIC ENZYME INCREASED 184 0.0027
799 MUSCLE TIGHTNESS 43 0.0027
800 MUSCULOSKELETAL CHEST PAIN 41 0.0026
801 DRUG EFFECT INCOMPLETE 96 0.0026
802 INTERNATIONAL NORMALISED RATIO INCREASED 75 0.0026
803 SCAB 30 0.0026
804 FAECES DISCOLOURED 57 0.0026
805 BACK PAIN 604 0.0026
806 RASH PAPULAR 58 0.0026
807 LACRIMATION INCREASED 78 0.0026
808 LETHARGY 148 0.0026
809 URINARY TRACT INFECTION 437 0.0026
810 BLOOD PRESSURE INCREASED 391 0.0026
811 CONFUSIONAL STATE 411 0.0025
812 CEREBRAL HAEMORRHAGE 91 0.0025
813 DRY SKIN 338 0.0025
814 RESPIRATORY DEPRESSION 31 0.0025
815 HAEMORRHOIDS 49 0.0025
816 CHROMATURIA 56 0.0025
817 RESPIRATORY DISORDER 74 0.0025
818 HYPOGLYCAEMIA 119 0.0025
819 NODULE 32 0.0024
820 COORDINATION ABNORMAL 34 0.0024
821 CONDITION AGGRAVATED 741 0.0024
822 MASS 34 0.0024
823 PHARYNGEAL OEDEMA 37 0.0024
824 BLOOD CREATINE PHOSPHOKINASE INCREASED 69 0.0024
825 THERAPEUTIC RESPONSE DECREASED 145 0.0024
826 DYSPEPSIA 234 0.0024
827 CORONARY ARTERY DISEASE 72 0.0024
828 BLOOD IRON DECREASED 28 0.0024
829 COVID-19 412 0.0023
830 SKIN EXFOLIATION 198 0.0023
831 CELLULITIS 118 0.0023
832 ALOPECIA 459 0.0023
833 HEPATITIS C 28 0.0023
834 JOINT STIFFNESS 60 0.0023
835 CARDIOVASCULAR DISORDER 58 0.0023
836 BEDRIDDEN 30 0.0023
837 IMMUNODEFICIENCY 34 0.0023
838 PALPITATIONS 267 0.0023
839 COUGH 638 0.0023
840 BLOOD PRESSURE ABNORMAL 45 0.0023
841 LIMB DISCOMFORT 70 0.0023
842 BLINDNESS 92 0.0023
843 CHOLELITHIASIS 74 0.0023
844 PULMONARY HYPERTENSION 47 0.0023
845 MUSCULOSKELETAL PAIN 118 0.0023
846 BRAIN FOG 35 0.0022
847 CYTOMEGALOVIRUS INFECTION 37 0.0022
848 ANGIOEDEMA 97 0.0022
849 DRY MOUTH 177 0.0022
850 RASH PRURITIC 118 0.0022
851 ORAL HERPES 42 0.0021
852 BONE PAIN 125 0.0021
853 FULL BLOOD COUNT DECREASED 43 0.0021
854 PRURITUS GENERALISED 46 0.0021
855 PAIN IN JAW 60 0.0021
856 RESPIRATORY ARREST 58 0.0021
857 CYSTITIS 67 0.0021
858 HOT FLUSH 157 0.0021
859 CEREBROVASCULAR ACCIDENT 352 0.0021
860 BLOOD TEST ABNORMAL 29 0.0021
861 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 113 0.0021
862 BLOOD PRESSURE SYSTOLIC INCREASED 40 0.0020
863 MYOCARDIAL INFARCTION 354 0.0020
864 FLATULENCE 115 0.0020
865 RESTLESSNESS 74 0.0020
866 EATING DISORDER 43 0.0020
867 DIZZINESS 1001 0.0020
868 VERTIGO 122 0.0020
869 HYPOKINESIA 29 0.0020
870 NIGHT SWEATS 64 0.0020
871 URTICARIA 327 0.0019
872 PANCREATIC CARCINOMA 56 0.0019
873 PHOTOSENSITIVITY REACTION 32 0.0019
874 SEIZURE 218 0.0019
875 RENAL INJURY 56 0.0019
876 ERUCTATION 36 0.0019
877 HEART RATE INCREASED 184 0.0019
878 HAEMATOMA 48 0.0019
879 BLISTER 101 0.0018
880 PELVIC PAIN 32 0.0018
881 BLOOD URINE PRESENT 33 0.0017
882 DISCOMFORT 105 0.0017
883 NEOPLASM MALIGNANT 114 0.0017
884 GASTROOESOPHAGEAL REFLUX DISEASE 137 0.0017
885 AGITATION 124 0.0017
886 DEAFNESS 44 0.0017
887 OSTEONECROSIS 55 0.0017
888 FREQUENT BOWEL MOVEMENTS 45 0.0017
889 DRUG INEFFECTIVE 2194 0.0017
890 POLLAKIURIA 69 0.0017
891 CONVULSION 94 0.0016
892 LIVER FUNCTION TEST INCREASED 35 0.0016
893 RASH GENERALISED 42 0.0016
894 SWELLING FACE 105 0.0016
895 BURNING SENSATION 109 0.0016
896 FRACTURE 29 0.0015
897 PRODUCT USE ISSUE 284 0.0015
898 SEROTONIN SYNDROME 29 0.0015
899 VISION BLURRED 207 0.0015
900 PAIN 910 0.0015
901 OROPHARYNGEAL PAIN 137 0.0015
902 GAIT DISTURBANCE 278 0.0015
903 BALANCE DISORDER 125 0.0014
904 PAIN IN EXTREMITY 426 0.0014
905 WOUND 40 0.0014
906 HEART RATE DECREASED 50 0.0014
907 RHABDOMYOLYSIS 58 0.0014
908 SKIN DISCOLOURATION 63 0.0014
909 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 40 0.0014
910 UPPER RESPIRATORY TRACT INFECTION 63 0.0014
911 RENAL DISORDER 63 0.0014
912 TINNITUS 62 0.0013
913 RASH MACULAR 47 0.0013
914 HERPES ZOSTER 77 0.0013
915 DIABETES MELLITUS 102 0.0013
916 ABDOMINAL DISCOMFORT 224 0.0013
917 VISUAL IMPAIRMENT 163 0.0013
918 ACNE 99 0.0013
919 DYSKINESIA 53 0.0013
920 PRODUCTIVE COUGH 62 0.0013
921 DEPRESSED MOOD 67 0.0013
922 PRODUCT PRESCRIBING ERROR 30 0.0013
923 SOMNOLENCE 251 0.0012
924 CARDIAC DISORDER 114 0.0012
925 NECK PAIN 68 0.0012
926 DISTURBANCE IN ATTENTION 65 0.0012
927 ADVERSE DRUG REACTION 107 0.0012
928 FALL 394 0.0012
929 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
930 ADVERSE EVENT 105 0.0011
931 PREMATURE BABY 34 0.0011
932 MOVEMENT DISORDER 36 0.0011
933 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 58 0.0011
934 RHINORRHOEA 71 0.0011
935 PERIPHERAL SWELLING 155 0.0010
936 NEPHROLITHIASIS 46 0.0010
937 MYALGIA 170 0.0010
938 CATARACT 59 0.0010
939 SLEEP DISORDER 68 0.0010
940 VISUAL ACUITY REDUCED 31 0.0009
941 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
942 ECZEMA 47 0.0009
943 SWELLING 82 0.0009
944 OCULAR HYPERAEMIA 41 0.0009
945 INSOMNIA 229 0.0009
946 ANXIETY 243 0.0009
947 HEADACHE 535 0.0009
948 MENTAL DISORDER 37 0.0008
949 UNDERDOSE 62 0.0008
950 CARDIAC FAILURE CONGESTIVE 68 0.0008
951 AMNESIA 54 0.0008
952 BRONCHITIS 60 0.0008
953 CHRONIC KIDNEY DISEASE 61 0.0008
954 MUSCULOSKELETAL STIFFNESS 70 0.0008
955 MATERNAL EXPOSURE DURING PREGNANCY 71 0.0008
956 SURGERY 46 0.0008
957 VAGINAL HAEMORRHAGE 34 0.0008
958 CONTUSION 75 0.0008
959 TREATMENT NONCOMPLIANCE 42 0.0008
960 MOBILITY DECREASED 55 0.0008
961 BLOOD GLUCOSE INCREASED 144 0.0008
962 FOETAL EXPOSURE DURING PREGNANCY 62 0.0008
963 NO ADVERSE EVENT 135 0.0007
964 HYPOACUSIS 32 0.0007
965 MEDICATION ERROR 41 0.0007
966 WEIGHT INCREASED 163 0.0007
967 THERAPY CESSATION 36 0.0007
968 NASAL CONGESTION 41 0.0007
969 FEELING ABNORMAL 167 0.0007
970 ARTHRALGIA 284 0.0007
971 DRY EYE 34 0.0007
972 HALLUCINATION 50 0.0007
973 EXPOSURE DURING PREGNANCY 41 0.0007
974 EYE PAIN 35 0.0006
975 INFLUENZA LIKE ILLNESS 50 0.0006
976 NASOPHARYNGITIS 111 0.0006
977 EYE IRRITATION 33 0.0006
978 OVERDOSE 123 0.0006
979 FLUID RETENTION 29 0.0006
980 UNEVALUABLE EVENT 42 0.0006
981 DEPRESSION 123 0.0005
982 MEMORY IMPAIRMENT 71 0.0005
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 90 0.0005
984 PROSTATE CANCER 38 0.0005
985 SINUSITIS 47 0.0005
986 INFLUENZA 50 0.0004
987 SKIN BURNING SENSATION 30 0.0004
988 MIGRAINE 29 0.0003
989 JOINT SWELLING 36 0.0003
990 ILLNESS 28 0.0003
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
992 PRODUCT QUALITY ISSUE 29 0.0002
993 INCORRECT DOSE ADMINISTERED 32 0.0001